News|Articles|December 1, 2005

FDA actions in brief

The injectable antibiotic ertapenem (Invanz, Merck) was approved by FDA to treat moderate-to-severe complicated foot infections due to indicated pathogens in patients who have diabetes without osteomyelitis

Newsletter

Get the latest industry news, event updates, and more from Managed healthcare Executive.


Latest CME